Edition:
United Kingdom

People: Lannett Company Inc (LCI.N)

LCI.N on New York Stock Exchange

5.49USD
24 Jun 2019
Change (% chg)

$-0.31 (-5.34%)
Prev Close
$5.80
Open
$5.76
Day's High
$5.76
Day's Low
$5.47
Volume
17,422
Avg. Vol
283,701
52-wk High
$14.65
52-wk Low
$3.34

Abt, John 

Mr. John M. Abt is the Vice President and Chief Quality and Operations Officer of the Company. Prior to joining the Company, Mr. Abt held senior level positons in both quality and operations and has extensive knowledge in pharmaceutical manufacturing, quality, strategy, business improvement and site transformation. He most recently served as Teva Pharmaceuticals’ Vice President Global Quality Strategy, overseeing the development and implementation of strategy and associated initiatives for the global quality organization. Before that, he held a number of leadership positions of increasing responsibility in operations, continuous improvement, quality systems and compliance. He earned his Doctorate in Business Administration from Temple University, Masters of Administrative Science in Business Management from Johns Hopkins University and a Bachelor of Science in Biochemistry from Niagara University. Vice President and Chief Quality and Operations Officer.

Basic Compensation

Total Annual Compensation, USD 299,539
Restricted Stock Award, USD 153,505
Long-Term Incentive Plans, USD --
All Other, USD 111,969
Fiscal Year Total, USD 565,013

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Patrick LePore

129,785

Timothy Crew

1,329,780

Martin Galvan

763,745

John Abt

565,013

Maureen Cavanaugh

--

Grant Brock

--
As Of  30 Jun 2018